| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Solute carrier family 2, facilitated glucose transporter member 1 |
|---|
| Ligand | BDBM453245 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ATP Assay |
|---|
| IC50 | 55±n/a nM |
|---|
| Citation |  Olszewski, K; Poyurovsky, M; Barsotti, A; Kim, J; Liu, KG Treatment of infectious diseases with glucose uptake inhibitors US Patent US10729691 Publication Date 8/4/2020 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Solute carrier family 2, facilitated glucose transporter member 1 |
|---|
| Name: | Solute carrier family 2, facilitated glucose transporter member 1 |
|---|
| Synonyms: | GLUT-1 | GLUT1 | GTR1_HUMAN | Glucose Transporter 1 (hGLUT1) | Glucose transporter | Glucose transporter type 1, erythrocyte/brain | HepG2 glucose transporter | SLC2A1 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 54091.71 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 492 |
|---|
| Sequence: | MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTT
LTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFE
MLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIM
GNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHD
LQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEK
AGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQ
LPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGM
CFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPE
ELFHPLGADSQV
|
|
|
|---|
| BDBM453245 |
|---|
| n/a |
|---|
| Name | BDBM453245 |
|---|
| Synonyms: | 2-(3-(4-((4-(1H-pyrazol-4-yl)phenyl)amino)-5,7-dihydrofuro[3,4-d]pyrimidin-2-yl)phenoxy)-N-neopentylacetamide | US10729691, Example 30 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H30N6O3 |
|---|
| Mol. Mass. | 498.5762 |
|---|
| SMILES | CC(C)(C)CNC(=O)COc1cccc(c1)-c1nc2COCc2c(Nc2ccc(cc2)-c2cn[nH]c2)n1 |
|---|
| Structure | 
|
|---|
Search and Browse
